The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Expert perspective: Inside Accelerator™ Drug Development, 360° CDMO and CRO solution
Meet Thermo Fisher Scientific’s subject matter experts as they share insights, experience, and guidance to help biotech and pharma companies navigate every stage of drug development.
As drug development programs move from discovery through clinical trials, every phase introduces new scientific, operational, and regulatory challenges. Traditionally, biotechnology and pharmaceutical companies have relied on multiple third-party vendors throughout this journey, which can create fragmented processes, communication gaps, and costly delays.
Accelerator™ Drug Development simplifies that complexity by bringing together connected expertise, shared governance, and seamless execution across the development lifecycle.
Through an end-to-end approach, Thermo Fisher Scientific serves as a single strategic partner—integrating drug substance and drug product development and manufacturing, analytical services, clinical supply, clinical operations, and project management. With one coordinated team aligning strategies and timelines, your team can stay focused on advancing the science.
What integrated services and solutions does Accelerator™ Drug Development include?
- Early development
- Drug product manufacturing
- Clinical trial strategy
- Clinical supply
- Clinical trial execution
- Enabling technologies
- Integrated project management
Watch our new video to see how Accelerator™ Drug Development seamlessly brings together Thermo Fisher Scientific's integrated CDMO and CRO capabilities to help biotech and pharma companies save time and money, reduce risk, and expedite the path to market.